EXAGEN INC. - COMMON STOCK
3,0000
04-октября-24 15:59:54
15 мин. задержка
Акции
+0,0400
+1,35%
Сегодняшний диапазон
2,8896 - 3,0300
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Exagen Inc. Reports Strong Second Quarter 2023 Results
07 авг 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
26 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
25 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
30 май 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Reports First Quarter 2023 Results
15 май 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Announces Campaign for Lupus Awareness Month
01 май 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
24 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
20 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
06 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in Upcoming March Conferences
27 фев 2023 09:00:01 Источник Nasdaq GlobeNewswire
-
30 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
23 янв 2023 09:00:00 Источник Nasdaq GlobeNewswire
-
Exagen Inc. Reports Third Quarter 2022 Results
14 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
08 ноя 2022 16:05:02 Источник Nasdaq GlobeNewswire
-
Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
31 окт 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Exagen Announces Appointment of John Aballi as CEO
17 окт 2022 09:00:00 Источник Nasdaq GlobeNewswire
-
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
04 окт 2022 08:25:00 Источник Nasdaq GlobeNewswire
-
Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
20 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
01 сен 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA
04 авг 2022 16:06:00 Источник Nasdaq GlobeNewswire